...
首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Synthesis and biological evaluation of biguanide and dihydrotriazine derivatives as potential inhibitors of dihydrofolate reductase of opportunistic microorganisms
【24h】

Synthesis and biological evaluation of biguanide and dihydrotriazine derivatives as potential inhibitors of dihydrofolate reductase of opportunistic microorganisms

机译:双胍和二氢嗪衍生物作为机会微生物二氢醇还原酶潜在抑制剂的合成与生物学评价

获取原文
获取原文并翻译 | 示例
           

摘要

Twenty-one biguanide and dihydrotriazine derivatives were synthesized and evaluated as inhibitors of dihydrofolate reductase (DHFR) from opportunistic microorganisms: Pneumocystis carinii (pc), Toxoplasma gondii (tg), Mycobacterium avium (ma), and rat liver (rl). The most potent compound in the series was B2-07 with 12nM activity against tgDHFR. The most striking observation was that B2-07 showed similar potency to trimetrexate, ~233-fold improved potency over trimethoprim and ~7-fold increased selectivity as compared to trimetrexate against tgDHFR. Molecular docking studies in the developed homology model of tgDHFR rationalized the observed potency of B2-07. This molecule can act as a good lead for further design of molecules with better selectivity and improved potency.
机译:合成二十一胍和二氢嗪衍生物,并评价来自机会微生物的二氢溶胶还原酶(DHFR)的抑制剂:肺细胞肠道(PC),弓形虫(PC),分枝杆菌(MA)和大鼠肝(R1)。 该系列中最有效的化合物是B2-07,对TGDHFR进行12nm活性。 最引人注目的观察是B2-07与甲肾上腺素的〜233倍改善效力〜7倍,选择性与Timetrexate相比,与Tjdhfr相比,〜7倍的效力相似。 TGDHFR发达的同源模型中的分子对接研究理合格化B2-07观察到的效力。 该分子可以充当具有更好选择性和改善效力的分子的良好铅。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号